109 related articles for article (PubMed ID: 15499989)
21. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
22. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
[TBL] [Abstract][Full Text] [Related]
23. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
[TBL] [Abstract][Full Text] [Related]
24. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
[TBL] [Abstract][Full Text] [Related]
25. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
Lehmann S; Paul C; Törmä H
Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
[TBL] [Abstract][Full Text] [Related]
27. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
28. [The expression of matrix metalloproteinase-9 and tumor necrosis factor-alpha in cholesteatoma].
Li N; Qin Z; Dong M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):424-6. PubMed ID: 15499988
[TBL] [Abstract][Full Text] [Related]
29. Expression of the p53 and nm23 genes in cholesteatoma.
Bayazit YA; Bakir K; Kanlikama M; Ozer E; Mumbuc S; Disikirik I; Ucak R
Acta Otolaryngol; 2002 Oct; 122(7):726-9. PubMed ID: 12484649
[TBL] [Abstract][Full Text] [Related]
30. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta.
Miyazaki H; Kojima H; Tanaka Y; Shiwa M; Koga T; Moriyama H
Laryngoscope; 1999 Nov; 109(11):1785-92. PubMed ID: 10569408
[TBL] [Abstract][Full Text] [Related]
31. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
Li Z; Li X; Liu G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
[TBL] [Abstract][Full Text] [Related]
32. Expression of female sex hormone receptors in human middle-ear cholesteatomas.
Raynov AM; Choung YH; Moon SK; Park K
J Laryngol Otol; 2005 Dec; 119(12):941-5. PubMed ID: 16354354
[TBL] [Abstract][Full Text] [Related]
33. The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma.
Kim KH; Lim HJ; Kim YJ; Kim SW; Kim YS; Tian C; Park K; Park TJ; Choung YH
Acta Otolaryngol; 2014 Mar; 134(3):238-43. PubMed ID: 24460153
[TBL] [Abstract][Full Text] [Related]
34. Expression of toll-like receptors in chronic otitis media and cholesteatoma.
Hirai H; Kariya S; Okano M; Fukushima K; Kataoka Y; Maeda Y; Nishizaki K
Int J Pediatr Otorhinolaryngol; 2013 May; 77(5):674-6. PubMed ID: 23380629
[TBL] [Abstract][Full Text] [Related]
35. EGFR expression in acquired middle ear cholesteatoma in children and adults.
Alves AL; Pereira CS; Carvalho Mde F; Fregnani JH; Ribeiro FQ
Eur J Pediatr; 2012 Feb; 171(2):307-10. PubMed ID: 21800041
[TBL] [Abstract][Full Text] [Related]
36. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
[TBL] [Abstract][Full Text] [Related]
37. [The expression and significance of DDR2 and MMP-13in human middle ear cholesteatoma].
Xu LF; Sun WZ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):938-941. PubMed ID: 29771058
[No Abstract] [Full Text] [Related]
38. Alteration of epidermal differentiation in middle ear cholesteatoma.
Stammberger M; Bujía J; Kastenbauer E
Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
40. Expression of retinoic acid receptor beta in dermatofibrosarcoma protuberans.
Xiaoli Z; Qinhe F
J Cutan Pathol; 2009 Nov; 36(11):1141-5. PubMed ID: 19469866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
